149 related articles for article (PubMed ID: 38415536)
1. Computational Insights into the Interaction of Pinostrobin with Bcl-2 Family Proteins: A Molecular Docking Analysis.
Gunasekaran V; Dhakshinamurthy SS
Asian Pac J Cancer Prev; 2024 Feb; 25(2):507-512. PubMed ID: 38415536
[TBL] [Abstract][Full Text] [Related]
2. Molecular dynamic simulations on an inhibitor of anti-apoptotic Bcl-2 proteins for insights into its interaction mechanism for anti-cancer activity.
Anantram A; Kundaikar H; Degani M; Prabhu A
J Biomol Struct Dyn; 2019 Aug; 37(12):3109-3121. PubMed ID: 30526410
[TBL] [Abstract][Full Text] [Related]
3. Homology Modeling and Docking Studies of Bcl-2 and Bcl-xL with Small Molecule Inhibitors: Identification and Functional Studies.
Salam AAA; Nayek U; Sunil D
Curr Top Med Chem; 2018; 18(31):2633-2663. PubMed ID: 30659540
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis for Bcl-2 homology 3 domain recognition in the Bcl-2 protein family: identification of conserved hot spot interactions.
Moroy G; Martin E; Dejaegere A; Stote RH
J Biol Chem; 2009 Jun; 284(26):17499-511. PubMed ID: 19293158
[TBL] [Abstract][Full Text] [Related]
5. Molecular docking studies of anti-apoptotic BCL-2, BCL-XL, and MCL-1 proteins with ginsenosides from Panax ginseng.
Sathishkumar N; Sathiyamoorthy S; Ramya M; Yang DU; Lee HN; Yang DC
J Enzyme Inhib Med Chem; 2012 Oct; 27(5):685-92. PubMed ID: 21919598
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of functional redundancy among anti-apoptotic Bcl-2 proteins and its role in cancer cell survival.
Eichhorn JM; Alford SE; Sakurikar N; Chambers TC
Exp Cell Res; 2014 Apr; 322(2):415-24. PubMed ID: 24556425
[TBL] [Abstract][Full Text] [Related]
7. Effect of HA14-1 on apoptosis-regulating proteins in HeLa cells.
Rehman K; Tariq M; Akash MS; Gillani Z; Qazi MH
Chem Biol Drug Des; 2014 Mar; 83(3):317-23. PubMed ID: 24118733
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel potent inhibitors against Bcl-xL anti-apoptotic protein using docking studies.
Shipra G; Gauri M; Chandra PM; Kishore SP
Protein Pept Lett; 2012 Dec; 19(12):1302-17. PubMed ID: 22670675
[TBL] [Abstract][Full Text] [Related]
9. Interactions of pro-apoptotic BH3 proteins with anti-apoptotic Bcl-2 family proteins measured in live MCF-7 cells using FLIM FRET.
Liu Q; Leber B; Andrews DW
Cell Cycle; 2012 Oct; 11(19):3536-42. PubMed ID: 22895112
[TBL] [Abstract][Full Text] [Related]
10. BM-1197: a novel and specific Bcl-2/Bcl-xL inhibitor inducing complete and long-lasting tumor regression in vivo.
Bai L; Chen J; McEachern D; Liu L; Zhou H; Aguilar A; Wang S
PLoS One; 2014; 9(6):e99404. PubMed ID: 24901320
[TBL] [Abstract][Full Text] [Related]
11. Selectivity mechanism of BCL-XL/2 inhibition through
Luan J; Hu B; Wang S; Liu H; Lu S; Li W; Sun X; Shi J; Wang J
Phys Chem Chem Phys; 2022 Jul; 24(28):17105-17115. PubMed ID: 35791860
[TBL] [Abstract][Full Text] [Related]
12. Identification of anti-cancer organometallic compounds by inhibition of BCL-2/Bax interactions.
Afzal M; Alarifi A; Abduh NAY; Ayub A; Muddassir M
Comput Biol Med; 2023 Dec; 167():107657. PubMed ID: 37931525
[TBL] [Abstract][Full Text] [Related]
13. Cleavage of anti-apoptotic Bcl-2 family members after TCR stimulation contributes to the decision between T cell activation and apoptosis.
Guerrero AD; Welschhans RL; Chen M; Wang J
J Immunol; 2013 Jan; 190(1):168-73. PubMed ID: 23203923
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins.
Lee MS; Ha JH; Yoon HS; Lee CK; Chi SW
Biochem Biophys Res Commun; 2014 Feb; 445(1):120-5. PubMed ID: 24491548
[TBL] [Abstract][Full Text] [Related]
15. In silico SELEX screening and statistical analysis of newly designed 5mer peptide-aptamers as Bcl-xl inhibitors using the Taguchi method.
Poustforoosh A; Faramarz S; Nematollahi MH; Hashemipour H; Negahdaripour M; Pardakhty A
Comput Biol Med; 2022 Jul; 146():105632. PubMed ID: 35617726
[TBL] [Abstract][Full Text] [Related]
16. Isolation, characterisation, anticancer and anti-oxidant activities of 2-methoxy mucic acid from
Parthiban A; Sachithanandam V; Lalitha P; Muthukumaran J; Misra R; Jain M; Sridhar R; Mageswaran T; Purvaja R; Ramesh R
J Biomol Struct Dyn; 2023 Mar; 41(4):1424-1436. PubMed ID: 34963406
[TBL] [Abstract][Full Text] [Related]
17. The anti-apoptotic protein BCL2L1/Bcl-xL is neutralized by pro-apoptotic PMAIP1/Noxa in neuroblastoma, thereby determining bortezomib sensitivity independent of prosurvival MCL1 expression.
Hagenbuchner J; Ausserlechner MJ; Porto V; David R; Meister B; Bodner M; Villunger A; Geiger K; Obexer P
J Biol Chem; 2010 Mar; 285(10):6904-12. PubMed ID: 20051518
[TBL] [Abstract][Full Text] [Related]
18. Phytosterols and triterpenes from
Adewole KE; Ishola AA
J Recept Signal Transduct Res; 2019 Feb; 39(1):87-97. PubMed ID: 31215288
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis for the interplay of apoptosis and proliferation mediated by Bcl-xL:Bim interactions in pancreatic cancer cells.
Abrol R; Edderkaoui M; Goddard WA; Pandol SJ
Biochem Biophys Res Commun; 2012 Jun; 422(4):596-601. PubMed ID: 22609401
[TBL] [Abstract][Full Text] [Related]
20. N'-((2-(6-bromo-2-oxo-2H-chromen-3-yl)-1H-indol-3-yl)methylene)benzohydrazide as a probable Bcl-2/Bcl-xL inhibitor with apoptotic and anti-metastatic potential.
Kamath PR; Sunil D; Ajees AA; Pai KS; Biswas S
Eur J Med Chem; 2016 Sep; 120():134-47. PubMed ID: 27187865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
